IR-Med (IRME) Gains from Investment Securities (2022 - 2025)

IR-Med's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $15.5 million for Q2 2025.

• In Q2 2025, Gains from Investment Securities rose 744.03% year-over-year to $15.5 million; the TTM figure through Jun 2025 stood at $15.5 million (up 744.03% YoY), while the FY2024 annual figure was $15.1 million, down 3.04% from the prior year.
• Gains from Investment Securities came in at $15.5 million for Q2 2025 at IR-Med, up from $14.9 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $15.5 million in Q4 2023 to a low of $200000.0 in Q2 2022.
• A 4-year average of $9.2 million and a median of $13.9 million in 2022 frame the typical range for Gains from Investment Securities.
• Across the five-year window, Gains from Investment Securities declined 3.04% in 2024 and soared 930.89% in 2025, its largest moves.
• IR-Med's Gains from Investment Securities stood at $13.9 million in 2022, then gained by 11.48% to $15.5 million in 2023, then retreated by 3.04% to $15.1 million in 2024, then increased by 2.56% to $15.5 million in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $15.5 million, $14.9 million, and $15.1 million for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison